These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 17161223

  • 1. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism.
    Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Minisola S, D' Erasmo E, Mazzuoli GF, Letizia C.
    Metabolism; 2007 Jan; 56(1):30-6. PubMed ID: 17161223
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism.
    Bhadada SK, Bhansali A, Shah VN, Rao DS.
    Singapore Med J; 2011 Dec; 52(12):890-3. PubMed ID: 22159932
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS, Park JS, Cho MH, Jee SH, Lee HS, Ahn CW, Lowe WL, Kim KR.
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [Abstract] [Full Text] [Related]

  • 8. Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women.
    Ahlström T, Hagström E, Larsson A, Rudberg C, Lind L, Hellman P.
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):673-8. PubMed ID: 19250270
    [Abstract] [Full Text] [Related]

  • 9. Adipocytokines and breast cancer risk.
    Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, Sun Y, Wu Q, Chen L.
    Chin Med J (Engl); 2007 Sep 20; 120(18):1592-6. PubMed ID: 17908478
    [Abstract] [Full Text] [Related]

  • 10. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword.
    Park W, Kim BS, Lee JE, Huh JK, Kim BJ, Sung KC, Kang JH, Lee MH, Park JR, Rhee EJ, Oh KW, Lee WY, Park CY, Park SW, Kim SW.
    Diabetes Res Clin Pract; 2009 Jan 20; 83(1):119-25. PubMed ID: 19101054
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Relation of serum leptin and adiponectin to cardiovascular risk factors in older adults: a Guangzhou biobank cohort study-CVD].
    Bao B, Xu L, Jiang CQ, Jin YL, Liu B, Thomas G, Lam TH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb 20; 31(2):121-5. PubMed ID: 21215066
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K, Reese CE, Mason MP, Beaird LC, Tudor-Locke C, Vaughan LA.
    J Am Diet Assoc; 2008 Jun 20; 108(6):948-59. PubMed ID: 18502225
    [Abstract] [Full Text] [Related]

  • 15. Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome.
    Hallikainen M, Kolehmainen M, Schwab U, Laaksonen DE, Niskanen L, Rauramaa R, Pihlajamäki J, Uusitupa M, Miettinen TA, Gylling H.
    Clin Chim Acta; 2007 Aug 20; 383(1-2):126-32. PubMed ID: 17573060
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
    Poulain M, Doucet M, Drapeau V, Fournier G, Tremblay A, Poirier P, Maltais F.
    Chron Respir Dis; 2008 Aug 20; 5(1):35-41. PubMed ID: 18303100
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men.
    Gouni-Berthold I, Berthold HK, Chamberland JP, Krone W, Mantzoros CS.
    Clin Endocrinol (Oxf); 2008 Apr 20; 68(4):536-41. PubMed ID: 17973945
    [Abstract] [Full Text] [Related]

  • 20. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.
    Yun JE, Sull JW, Lee HY, Park E, Kim S, Jo J, Lee SJ, Kim SY, Choi YJ, Jee SH, Huh KB.
    Diabetes Metab Res Rev; 2009 Mar 20; 25(3):259-65. PubMed ID: 19214966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.